Mesenchymal stem cell therapy in intracerebral haemorrhagic stroke

Gloria Bedini, Anna Bersano, Elisa R. Zanier, Francesca Pischiutta, Eugenio A. Parati

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Background: Spontaneous intracerebral haemorrhage (ICH) is a relatively common fatal disease, with an overall global incidence estimated at 24.6 per 100,000 person-years. Given the high degree of morbidity and mortality associated with ICH, therapies that may have neuroprotective effects are of increasing interest to clinicians. In this last context, cell therapies offer the promise of improving the disease course which cannot be addressed adequately by existing treatments. Objective: The aim of this review is to evaluate the protective effects and molecular mechanisms of mesenchymal stem cells (MSCs) on haemorrhagic brain following ICH. We also discuss possible emerging therapeutic approaches worth of further research. Methods and Results: The available literature on the therapeutic potential of MSCs in ICH animal models clearly demonstrated that MSCs enhance the functional recovery and reduce the volume of the infarct size exerting anti-inflammatory and angiogenic properties. However, the quality of the original articles investigating the efficacy of stem cell therapies in ICH animal models is still poor and the lack of ICH clinical trial does not permit to reach any relevant conclusions. Conclusion: Further studies have to be implemented in order to achieve standardized methods of MSCs isolation, characterization and administration to improve ICH treatments with MSCs or MSC-derived products.

Original languageEnglish
Pages (from-to)2176-2197
Number of pages22
JournalCurrent Medicinal Chemistry
Volume25
Issue number19
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Cerebral Hemorrhage
Cell- and Tissue-Based Therapy
Stem cells
Mesenchymal Stromal Cells
Stroke
Animals
Animal Models
Therapeutics
Cell Separation
Neuroprotective Agents
Brain
Anti-Inflammatory Agents
Stem Cells
Clinical Trials
Morbidity
Recovery
Mortality
Incidence
Research

Keywords

  • Angiogenesis
  • Anti-inflammatory properties
  • Extracellular vesicles
  • Intracerebral haemorrhagic stroke
  • Mesenchymal
  • Neuroprotective action
  • Stem cells
  • Stroke

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

Cite this

Mesenchymal stem cell therapy in intracerebral haemorrhagic stroke. / Bedini, Gloria; Bersano, Anna; Zanier, Elisa R.; Pischiutta, Francesca; Parati, Eugenio A.

In: Current Medicinal Chemistry, Vol. 25, No. 19, 01.01.2018, p. 2176-2197.

Research output: Contribution to journalReview article

Bedini, Gloria ; Bersano, Anna ; Zanier, Elisa R. ; Pischiutta, Francesca ; Parati, Eugenio A. / Mesenchymal stem cell therapy in intracerebral haemorrhagic stroke. In: Current Medicinal Chemistry. 2018 ; Vol. 25, No. 19. pp. 2176-2197.
@article{2ec582fb905b4d36aed82d3aaa15998b,
title = "Mesenchymal stem cell therapy in intracerebral haemorrhagic stroke",
abstract = "Background: Spontaneous intracerebral haemorrhage (ICH) is a relatively common fatal disease, with an overall global incidence estimated at 24.6 per 100,000 person-years. Given the high degree of morbidity and mortality associated with ICH, therapies that may have neuroprotective effects are of increasing interest to clinicians. In this last context, cell therapies offer the promise of improving the disease course which cannot be addressed adequately by existing treatments. Objective: The aim of this review is to evaluate the protective effects and molecular mechanisms of mesenchymal stem cells (MSCs) on haemorrhagic brain following ICH. We also discuss possible emerging therapeutic approaches worth of further research. Methods and Results: The available literature on the therapeutic potential of MSCs in ICH animal models clearly demonstrated that MSCs enhance the functional recovery and reduce the volume of the infarct size exerting anti-inflammatory and angiogenic properties. However, the quality of the original articles investigating the efficacy of stem cell therapies in ICH animal models is still poor and the lack of ICH clinical trial does not permit to reach any relevant conclusions. Conclusion: Further studies have to be implemented in order to achieve standardized methods of MSCs isolation, characterization and administration to improve ICH treatments with MSCs or MSC-derived products.",
keywords = "Angiogenesis, Anti-inflammatory properties, Extracellular vesicles, Intracerebral haemorrhagic stroke, Mesenchymal, Neuroprotective action, Stem cells, Stroke",
author = "Gloria Bedini and Anna Bersano and Zanier, {Elisa R.} and Francesca Pischiutta and Parati, {Eugenio A.}",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/0929867325666180111101410",
language = "English",
volume = "25",
pages = "2176--2197",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "19",

}

TY - JOUR

T1 - Mesenchymal stem cell therapy in intracerebral haemorrhagic stroke

AU - Bedini, Gloria

AU - Bersano, Anna

AU - Zanier, Elisa R.

AU - Pischiutta, Francesca

AU - Parati, Eugenio A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Spontaneous intracerebral haemorrhage (ICH) is a relatively common fatal disease, with an overall global incidence estimated at 24.6 per 100,000 person-years. Given the high degree of morbidity and mortality associated with ICH, therapies that may have neuroprotective effects are of increasing interest to clinicians. In this last context, cell therapies offer the promise of improving the disease course which cannot be addressed adequately by existing treatments. Objective: The aim of this review is to evaluate the protective effects and molecular mechanisms of mesenchymal stem cells (MSCs) on haemorrhagic brain following ICH. We also discuss possible emerging therapeutic approaches worth of further research. Methods and Results: The available literature on the therapeutic potential of MSCs in ICH animal models clearly demonstrated that MSCs enhance the functional recovery and reduce the volume of the infarct size exerting anti-inflammatory and angiogenic properties. However, the quality of the original articles investigating the efficacy of stem cell therapies in ICH animal models is still poor and the lack of ICH clinical trial does not permit to reach any relevant conclusions. Conclusion: Further studies have to be implemented in order to achieve standardized methods of MSCs isolation, characterization and administration to improve ICH treatments with MSCs or MSC-derived products.

AB - Background: Spontaneous intracerebral haemorrhage (ICH) is a relatively common fatal disease, with an overall global incidence estimated at 24.6 per 100,000 person-years. Given the high degree of morbidity and mortality associated with ICH, therapies that may have neuroprotective effects are of increasing interest to clinicians. In this last context, cell therapies offer the promise of improving the disease course which cannot be addressed adequately by existing treatments. Objective: The aim of this review is to evaluate the protective effects and molecular mechanisms of mesenchymal stem cells (MSCs) on haemorrhagic brain following ICH. We also discuss possible emerging therapeutic approaches worth of further research. Methods and Results: The available literature on the therapeutic potential of MSCs in ICH animal models clearly demonstrated that MSCs enhance the functional recovery and reduce the volume of the infarct size exerting anti-inflammatory and angiogenic properties. However, the quality of the original articles investigating the efficacy of stem cell therapies in ICH animal models is still poor and the lack of ICH clinical trial does not permit to reach any relevant conclusions. Conclusion: Further studies have to be implemented in order to achieve standardized methods of MSCs isolation, characterization and administration to improve ICH treatments with MSCs or MSC-derived products.

KW - Angiogenesis

KW - Anti-inflammatory properties

KW - Extracellular vesicles

KW - Intracerebral haemorrhagic stroke

KW - Mesenchymal

KW - Neuroprotective action

KW - Stem cells

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85048884996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048884996&partnerID=8YFLogxK

U2 - 10.2174/0929867325666180111101410

DO - 10.2174/0929867325666180111101410

M3 - Review article

VL - 25

SP - 2176

EP - 2197

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 19

ER -